#cdmo — Public Fediverse posts

Fuji Keizai: Japan Pharma Capex Up 50% to 946 Billion Yen

KEY POINTSFuji Keizai survey shows 25 Japanese drugmakers’ capital spending reaches 946 billion yen in 2025, about 50% above 2022Capital expenditure rises to about 6% of sales from…
#Japan #JP #JapanNews #ADC #biopharmaceuticals #capitalexpenditure #CDMO #drugmanufacturing #FujiKeizai #Japanpharmaceuticals #Japanese #Japanesenews #mRNAvaccines #news
https://www.alojapan.com/1517590/fuji-keizai-japan-pharma-capex-up-50-to-946-billion-yen/

https://www.alojapan.com/1517590/fuji-keizai-japan-pharma-capex-up-50-to-946-billion-yen/ Fuji Keizai: Japan Pharma Capex Up 50% to 946 Billion Yen #ADC #biopharmaceuticals #CapitalExpenditure #CDMO #DrugManufacturing #FujiKeizai #Japan #JapanNews #JapanPharmaceuticals #Japanese #JapaneseNews #MRNAVaccines #news KEY POINTSFuji Keizai survey shows 25 Japanese drugmakers’ capital spending reaches 946 billion yen in 2025, about 50% above 2022Capital expenditure rises to about 6% of sales from 5% as manufacturers invest in newer drug

PolyPeptide shareholders overwhelmingly approved all Board proposals at AGM 2026, with 80.85% share representation. All directors re-elected, affirming strong governance. #Pharma #CDMO

EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan

TOKYO, April 29, 2026 /PRNewswire/ — As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces—policy evol…
#Japan #JP #JapanNews #CDMO #CPHIJapan #development #manufacturing #news #supplychain #supplychainresilience
https://www.alojapan.com/1480461/eirgenix-advances-into-cphi-japan-capitalizing-on-market-trends-to-deepen-its-strategic-footprint-in-japan/

https://www.alojapan.com/1480461/eirgenix-advances-into-cphi-japan-capitalizing-on-market-trends-to-deepen-its-strategic-footprint-in-japan/ EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan #CDMO #CPHIJapan #development #Japan #JapanNews #manufacturing #news #SupplyChain #SupplyChainResilience TOKYO, April 29, 2026 /PRNewswire/ — As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces—policy evolution and supply chain transformation—are reshaping Japan’s landscape. On one side, the Minis

If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

I'm trying to push for an open-source #ERP and looking for suggestions.Working at a #CDMO, supply chain department. Currently looking at odoo. Boost's appreciated :apartyblob: